Now antibiotic resistant bacteria are one of the biggest threats to global health. As scientists scramble to find solutions, a recent study concludes that a compound found in green tea might boost existing drugs.
A recent study investigated epigallocatechin, which is a compound in green tea.


Green tea has gained immense popularity across the globe, mainly because of its health benefits. Green tea extract has been used for many purposes for weight loss, improved brain function, enhanced metabolism, and lower risk of some types of cancer, among others.

A natural antioxidant commonly found in green tea may help eliminate antibiotic resistant bacteria or super bugs, according to a study.

The study, published in the Journal of Medical Microbiology, found that the antioxidant epigallocatechin (EGCG) can restore the activity of aztreonam, an antibiotic commonly used to treat infections caused by the bacterial pathogen Pseudomonas aeruginosa.

Antibiotics have proven essential for treating bacterial infections since doctors first used them in the 1930s.

However, bacteria are rapidly becoming resistant to the drugs designed to kill them.

In the United States alone, drug resistant bacteria infect at least 2 million people each year, leading to about 23,000deaths, according to the Centers for Disease Control and Resistance (CDC).

As antibiotic resistant pathogens become increasingly prevalent, researchers are leaving no stone unturned in their search for innovative interventions.


Pseudomonas aeruginosa is a common encapsulated, Gram-negative, rod-shaped bacterium that can cause disease in plants and animals, including humans.

Investigation on Green tea compound epigallocatechin (EGCG)

However, the most recent study looking for ways to solve the antibiotic resistance crisis investigated green tea. The authors of the study conclude that one particular compound in green tea might bolster failing antibiotics and help them to kill bacteria more efficiently.

The researchers, from the University of Surrey School of Veterinary Medicine in Guildford, United Kingdom, focused on the bacterium Pseudomonas aeruginosa.

This bacterium can cause severe infections to the skin, the blood, and the respiratory and urinary tracts.

The bacteria are growing resistant to many antibiotics and are increasingly difficult to fight. Currently, doctors treat P.aeruginosa infections with a combination of antibiotics.

Green tea contains a compound known as epigallocatechin (EGCG). Researchers are interested in this polyphenol for several reasons. For instance, some studies have investigated whether it might treat inflammation and rheumatoid arthritis.

In the latest investigation, researchers combined EGCG with aztreonam, which is an antibiotic commonly used to fight P.aeruginosa. They found that the combination reduced the numbers of clinical multi drug resistant strains of P. aeruginosa in laboratory cultures.


Epigallocatechin gallate (EGCG)
The new study also investigated the interaction between EGCG and aztreonam in an animal model. Specifically, they used greater wax moth larvae, which scientists have found to be a useful model for studying antibiotics.

Additionally, they found that when they combined EGCG with aztreonam, it was more effective than using the drug or EGCG alone.

The research team believes that EGCG increases the bacterium's permeability, allowing antibiotics to pass through more easily.

People all over the world are at the risk of antibiotic resistance

Recently The World Health Organization(WHO) warns that taking antibiotics when they are not needed both by humans and livestock speeds up multi drug resistance and puts everyone at risk.

Now it is important to emphasize that it is not a person who becomes resistant, but the bacterium. This means that cures for common infections are under threat.

"Antimicrobial resistance (AMR) is a serious threat to global public health. Without effective antibiotics, the success of medical treatments will be compromised. We urgently need to develop novel antibiotics in the fight against AMR." The main author Dr. Jonathan Betts

Prof. Dr. Betts continues, "Natural products, such as EGCG, used in combination with currently licensed antibiotics, may be a way of improving their effectiveness and clinically useful lifespan."

Furthermore, Prof. Roberto La Ragione, Head of the Department of Pathology and Infectious Diseases at the School of Veterinary Medicine at the University of Surrey, explains the potential importance of these results:

"The WHO has listed antibiotic resistant P. aeruginosa as a critical threat to human health. We have shown that we can successfully eliminate such threats with the use of natural products, in combination with antibiotics already in use."


You may also like

Facebook Conversations

Disqus Conversations